img img img img

News

News

Arcutis buys UK’s Ducentis for up to $400M, as charity Lifearc celebrates first exit from venture arm – BioWorld Online

Arcutis buys UK’s Ducentis for up to $400M, as charity Lifearc celebrates first exit from venture arm  BioWorld Online Arcutis Biotherapeutics agrees to acquire LifeArc portfolio company Ducentis BioTherapeut  Seeking Alpha VC firm LifeArc sells first portfolio company as dermatitis-focused Ducentis bought by Arcutis for $30M  FierceBiotech View Full coverage on Google News